2018
Dear Shareholders,
the Annual General Shareholders’ Meeting of Epigenomics AG has taken place on May 30, 2018 in Berlin. Shareholders approved all agenda items according to the Board’s proposal.
| Voting results (only in German) | |
| Resolution passed on aganda items 6 to 8 |
| Invitation to the Annual General Shareholders’ Meeting 2018 of Epigenomics AG | |
| Report of the Executive Board on agenda items 6,7 and 8 | |
| Annual Report 2017 (incl. Consolidated Financial Statements, Group Management Report, Supervisory Board Report, Key features of the internal control and risk management system and Remuneration Report) |
|
| Financial Statements 2017 (German HGB) incl. Key features of the internal control and risk management system (German version) |
|
| Explanatory Report by the Management Board on Disclosures Pursuant to Section 289a (1), Section 315a (1) HGB (German Version) |
Corporate Governance/Declaration of Governance
| 2017 | |
| Declaration of Compliance with the German Corporate Governance Code pursuant to Section 161 of the German Stock Corporation Act (AktG) | |
| Declaration of Governance and reporting on Corporate Governance pursuant to Section 289a German Commercial Code (HGB) |
Further information
| Access to shareholder portal | Link |
| Explanation of Shareholders’ rights | |
| Articles of Association |
Counterproposals
| Counterproposal regarding agenda items 6, 7 and 8 (only in German) |